Table 1.
The Clinical Characteristics of the Gastric Cancer Patients
| Variables | No. (n = 114) | Percent |
|---|---|---|
| Age (years) | ||
| <60 | 38 | 33.3% |
| ≥60 | 76 | 66.7% |
| Gender | ||
| Male | 83 | 72.8% |
| Female | 31 | 27.2% |
| Diameter (cm) | ||
| <5 | 67 | 58.8% |
| ≥5 | 47 | 41.2% |
| CEA | ||
| Positive | 71 | 62.3% |
| Negative | 43 | 37.7% |
| CA19-9 | ||
| Positive | 58 | 50.9% |
| Negative | 56 | 49.1% |
| Differentiation | ||
| Well | 11 | 9.7% |
| Moderate | 47 | 41.2% |
| Poor | 56 | 49.1% |
| Lymphatic metastasis | ||
| Absent | 31 | 27.2% |
| Present | 83 | 72.8% |
| Invasion | ||
| Tis&T1–T3 | 37 | 32.5% |
| T4 | 77 | 67.5% |
| Distal metastasis | ||
| Absent | 71 | 62.3% |
| Present | 43 | 37.7% |
| TNM stage | ||
| 0–I | 25 | 21.9% |
| II | 22 | 19.3% |
| III | 24 | 21.1% |
| IV | 43 | 37.7% |
All samples consist of 23 endoscopic biopsy samples and 91 surgery samples from patients with gastric cancer.